Squarepoint’s SpringWorks Therapeutics SWTX Stock Holding History

Squarepoint’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,600	Closed	-$909K	–	5036
2025 Q1	$909K	Buy	+20,600	New	+$948K	﹤0.01%	2759

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Squarepoint's SWTX Position: Q3 2025 in Review

Squarepoint sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 204,271 shares — an estimated $9.6M sold.

Squarepoint first reported a position in SWTX in Q2 2020 and held it in 14 quarters. The position peaked at $9.6M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Squarepoint reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Squarepoint sold 204,271 SpringWorks Therapeutics shares in Q3 2025, an estimated $9.6M.
Squarepoint first reported a position in SpringWorks Therapeutics in Q2 2020 and held it in 14 quarters.
Squarepoint's SpringWorks Therapeutics position peaked at $9.6M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.